News BioLargo, Inc.

Equities

BLGO

US09065A1007

Market Closed - OTC Markets Other stock markets 03:58:31 2024-06-05 pm EDT			5-day change	1st Jan Change
0.272 ^USD	-1.98%		-9.63%	+61.90%

May. 14	Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14	BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024	May. 14
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024	Apr. 02
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
BioLargo to Present at The LD Micro Invitational XIV	Mar. 25	NE
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready	Feb. 22	AQ
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors	Feb. 12	CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment	Jan. 29	CI
BioLargo, Inc. announced that it has received $0.815 million in funding	Jan. 22	CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey	Dec. 20	CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022	Dec. 12	CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023	Nov. 20
BioLargo, Inc. announced that it expects to receive $0.815 million in funding	Nov. 16	CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
BioLargo, Inc. to Present at the LD Micro Main Event XVI	23-09-19	NE
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023	23-08-16
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast	23-06-05	NE
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-18	AQ
Transcript : BioLargo, Inc., Q1 2023 Earnings Call, May 18, 2023	23-05-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioLargo, Inc.

Equities

BLGO

US09065A1007

Summary

Filters